{"gene":"RRN3","run_date":"2026-06-10T07:46:28","timeline":{"discoveries":[{"year":1985,"finding":"TIF-IA is a growth-dependent transcription factor that co-purifies with RNA polymerase I and is required for accurate and efficient Pol I transcription initiation in vitro; its amount or activity fluctuates with the physiological state of cells (absent in quiescent cells).","method":"Partial purification of TIF-IA; in vitro transcription reconstitution with purified factors","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro transcription with purified factors, replicated across multiple subsequent studies","pmids":["4070001"],"is_preprint":false},{"year":1990,"finding":"TIF-IA physically associates with RNA polymerase I (converting it into a transcriptionally active holoenzyme capable of initiating at the rDNA promoter) and behaves analogously to a bacterial sigma factor: it is present in limiting amounts, associates with Pol I, is required for initiation, and is separable from the polymerase at certain salt conditions. Dephosphorylation of Pol I abolishes in vitro transcription initiation without affecting non-specific polymerizing activity.","method":"Biochemical co-fractionation, in vitro transcription reconstitution, phosphatase treatment of Pol I","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with multiple orthogonal biochemical approaches, foundational finding replicated widely","pmids":["2390974"],"is_preprint":false},{"year":1993,"finding":"Purified TIF-IA is a 75 kDa monomeric polypeptide that directly interacts with RNA Pol I and is a bona fide transcription initiation factor; preinitiation complexes can assemble without TIF-IA but formation of the first phosphodiester bonds requires TIF-IA; after initiation, TIF-IA is released from the initiation complex and can facilitate transcription from templates bearing preinitiation complexes lacking TIF-IA. Murine TIF-IA complements both mouse and human growth-inhibited cell extracts.","method":"Purified factor reconstitution, template commitment assay, in vitro transcription with purified components","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted with purified factors using multiple orthogonal assays","pmids":["8413268"],"is_preprint":false},{"year":1996,"finding":"Yeast Rrn3p is an essential RNA Pol I transcription factor that directly interacts with Pol I independently of DNA template; pre-incubation of Rrn3p with purified Pol I stimulates formation of a Sarkosyl-resistant pre-initiation complex, indicating Rrn3p stimulates Pol I recruitment to the promoter. Rrn3p is not part of the stable pre-initiation complex that supports multiple rounds of transcription.","method":"Genetic complementation (rrn3 mutant extracts), immunoaffinity purification, in vitro transcription with purified Rrn3p, template commitment assay, single-round transcription with Sarkosyl","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified components, multiple orthogonal assays (template commitment, single-round transcription, pre-incubation experiments)","pmids":["8670901"],"is_preprint":false},{"year":1997,"finding":"Yeast RRN3 is a multicopy suppressor of the cbf5-1 temperature-sensitive mutation; the cbf5-1 mutant shows a defect in rRNA biosynthesis at restrictive temperatures, placing RRN3 in a genetic pathway with CBF5/nucleolar function.","method":"High-copy suppressor screen, genetic epistasis in yeast","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic suppressor screen with phenotypic validation in yeast, single lab","pmids":["9315678"],"is_preprint":false},{"year":2000,"finding":"Yeast Pol I subunit A43 directly interacts with Rrn3: conditional mutations in A43 disrupt the Pol I–Rrn3 transcriptionally competent complex; the two proteins form a stable complex when co-expressed in E. coli; overexpression of Rrn3 suppresses A43 mutant phenotype; A43 and Rrn3 show synthetic lethality; immunoelectron microscopy confirms their co-localization within the Pol I–Rrn3 complex. Rrn3 also contacts the C-terminus of Rrn6 (core factor subunit) via affinity chromatography.","method":"Conditional yeast genetics, co-expression in E. coli, synthetic lethality, immunoelectron microscopy, two-hybrid screen, affinity chromatography","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (genetics, co-expression, EM localization, in vitro affinity), single lab but comprehensive","pmids":["11032814"],"is_preprint":false},{"year":2000,"finding":"Human TIF-IA is the mammalian ortholog of yeast Rrn3p: recombinant TIF-IA interacts with Pol I in the absence of template DNA, augments Pol I transcription in vivo, and rescues transcription in extracts from growth-arrested cells in vitro.","method":"Molecular cloning, in vitro transcription complementation assay, in vivo transcription augmentation","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro and in vivo functional reconstitution demonstrating conserved activity, single lab with multiple assays","pmids":["11265758"],"is_preprint":false},{"year":2000,"finding":"Human Rrn3 functionally rescues a yeast RRN3 disruption strain in vivo; a point mutation in a conserved amino acid compromises function of both yeast and human factors, confirming functional conservation across eukaryotes.","method":"Cross-species genetic complementation in yeast, site-directed mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vivo genetic complementation plus mutagenesis confirming conserved residue importance","pmids":["10758157"],"is_preprint":false},{"year":2002,"finding":"TIF-IA is associated with a fraction of TIF-IB/SL1 and initiation-competent Pol I. Nutrient starvation, density arrest, and cycloheximide inactivate TIF-IA and impair its association with Pol I. Deletion mapping shows that TIF-IA amino acids 512–609 interact with Pol I subunits RPA43 and PAF67, while residues 411–415 (LARAK motif) are required for association with TAF(I)95 and TAF(I)68 (SL1 subunits).","method":"Co-immunoprecipitation, deletion mutant mapping, in vitro interaction assays","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — domain mapping by deletion analysis and co-IP, single lab with multiple constructs","pmids":["12393749"],"is_preprint":false},{"year":2002,"finding":"Phosphorylation state of mammalian Rrn3 regulates its interaction with the rpa43 subunit of RNA Pol I and hence rDNA transcription: cycloheximide inhibits Rrn3 phosphorylation and causes its dissociation from Pol I; Rrn3 produced in Sf9 cells (phosphorylated) but not in bacteria interacts with rpa43 in vitro; neither dephosphorylated nor bacterially-produced Rrn3 restores transcription in cycloheximide-treated cell extracts.","method":"Co-immunoprecipitation, in vitro binding assay (Sf9 vs. bacterial recombinant protein), in vitro transcription complementation, phosphatase treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal assays (binding, transcription complementation) with biochemical controls, single lab","pmids":["12015311"],"is_preprint":false},{"year":2003,"finding":"ERK and RSK kinases phosphorylate TIF-IA at S633 and S649 in response to growth factor signaling; replacement of S649 with alanine inactivates TIF-IA, inhibits pre-rRNA synthesis, and retards cell growth. PD98059 (MEK inhibitor) blocks TIF-IA activation, confirming MAPK-dependent regulation.","method":"Phosphopeptide mapping, site-directed mutagenesis, in vitro kinase assay, PD98059 inhibitor treatment, cell growth assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — phosphopeptide mapping, mutagenesis, in vitro kinase assay, and in vivo functional consequences; replicated in concept by subsequent studies","pmids":["12620228"],"is_preprint":false},{"year":2003,"finding":"Mammalian Rrn3 functions stoichiometrically (not catalytically) in rDNA transcription: Rrn3 becomes inactivated during transcription reactions, dissociates from Pol I upon transcription, and the inactivated form cannot form a stable complex with Pol I.","method":"In vitro transcription assay with limiting factor analysis, sequential transcription reactions, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro transcription reconstitution demonstrating stoichiometric behavior, single lab","pmids":["12646563"],"is_preprint":false},{"year":2004,"finding":"mTOR regulates Pol I transcription through TIF-IA: rapamycin (mTOR inhibitor) inactivates TIF-IA, impairs transcription-initiation complex formation, and causes translocation of TIF-IA from nucleus to cytoplasm. Mechanistically, rapamycin causes hypophosphorylation of S44 and hyperphosphorylation of S199; S44 phosphorylation activates TIF-IA while S199 phosphorylation inactivates it.","method":"Rapamycin treatment, phosphopeptide mapping, site-directed mutagenesis, co-immunoprecipitation (TIF-IA with Pol I and SL1), immunofluorescence localization","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — phospho-mapping, mutagenesis, co-IP, and subcellular localization with functional consequences; widely replicated concept","pmids":["15004009"],"is_preprint":false},{"year":2005,"finding":"JNK2 inactivates TIF-IA under stress by phosphorylating it at T200; this phosphorylation impairs TIF-IA interaction with Pol I and TIF-IB/SL1, abrogates initiation complex formation, and causes translocation of TIF-IA from nucleolus to nucleoplasm. T200V substitution or Jnk2 knockout prevents inactivation/translocation and confers stress-resistance of Pol I transcription.","method":"In vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis, co-immunoprecipitation, immunofluorescence, genetic knockout (Jnk2-/-)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — kinase assay, mutagenesis, co-IP, localization, and genetic KO with multiple orthogonal readouts","pmids":["15805466"],"is_preprint":false},{"year":2005,"finding":"Genetic inactivation of TIF-IA in mice causes embryonic lethality (before/at E9.5). Conditional Cre-mediated depletion in MEFs leads to nucleolar disruption, cell cycle arrest, p53 upregulation, and apoptosis. Elevated p53 results from increased binding of ribosomal protein L11 to MDM2, decreasing MDM2–p53 and MDM2–p19(ARF) interactions. RNAi-mediated loss of p53 rescues proliferation arrest and apoptosis.","method":"Homologous recombination knockout in mice, Cre-mediated conditional depletion in MEFs, RNAi, co-immunoprecipitation (L11–MDM2, MDM2–p53), immunofluorescence","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined molecular mechanism (L11–MDM2 co-IP), rescue experiments, multiple orthogonal readouts","pmids":["15989966"],"is_preprint":false},{"year":2007,"finding":"In yeast, Pol I subunits Rpa49 and Rpa34 control both the recruitment of Rrn3 to the rDNA promoter and its release during elongation: rpa49 mutants lacking the C-terminus reduce polymerase occupancy and strongly impair Rrn3 release from elongating Pol I; this elongation defect is bypassed by an N-terminal deletion of Rpa43 (rpa43-35,326), placing Rpa43–Rrn3 interaction downstream of Rpa49 function.","method":"Yeast genetics (deletion/point mutants), ChIP, 6-azauracil/mycophenolate sensitivity, epistasis analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with ChIP in yeast, single lab","pmids":["18086878"],"is_preprint":false},{"year":2007,"finding":"Drosophila TIF-IA is required for rRNA synthesis and cell growth in vivo; the TOR pathway regulates TIF-IA recruitment to rDNA; TIF-IA overexpression maintains rRNA transcription when TOR activity is reduced, placing TIF-IA genetically downstream of TOR in growth control.","method":"Drosophila genetic analysis (Tif-IA null mutants), RNAi knockdown, epistasis with TOR pathway, ChIP (TIF-IA occupancy at rDNA)","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo genetic analysis with ChIP and epistasis in a multicellular organism, multiple orthogonal approaches","pmids":["18086911"],"is_preprint":false},{"year":2008,"finding":"CK2 phosphorylates TIF-IA at S170/172, triggering release of TIF-IA from Pol I after transcription initiation, which is required for transcription elongation. Inhibition of S170/172 phosphorylation or covalent tethering of TIF-IA to RPA43 inhibits rDNA transcription, perturbs nucleolar structure, and causes cell cycle arrest. Dephosphorylation of S170/172 by FCP1 phosphatase facilitates TIF-IA reassociation with Pol I for new rounds of transcription.","method":"In vitro kinase assay, site-directed mutagenesis, FRAP, ChIP, co-immunoprecipitation, chemical crosslinking (TIF-IA tethered to RPA43)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — kinase assay, mutagenesis, FRAP, ChIP, co-IP, and biochemical tethering with multiple functional readouts","pmids":["18559419"],"is_preprint":false},{"year":2008,"finding":"Mammalian Rrn3 is required for formation of a transcription-competent preinitiation complex: Pol I can be recruited to the rDNA template in the absence of active Rrn3 but the resulting complex cannot initiate transcription; the functional Rrn3-containing complex is ~5-fold more heparin-resistant than the non-functional complex.","method":"Novel ChIP-like template recruitment assay, heparin challenge, in vitro transcription","journal":"Gene expression","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — biochemical reconstitution with defined functional readout, single lab, single study","pmids":["18590050"],"is_preprint":false},{"year":2009,"finding":"TIF-IA dynamically shuttles between cytoplasm, nucleoplasm, and nucleolus with a mean nucleolar residence time of ~30 s; the majority of TIF-IA is in cytoplasm/nucleus with only ~7% in nucleoli at steady state. Import from cytoplasm to nucleus is ~3-fold faster than export, suggesting active importin/exportin-mediated transport. Upon ribotoxic stress, TIF-IA is released from nucleoli with a half-time of ~24 min, downstream of JNK2 activation as the rate-limiting step.","method":"Live-cell fluorescence microscopy (GFP-TIF-IA), FRAP, kinetic modeling, JNK2 activity time-course","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative live imaging with kinetic modeling and JNK2 activity validation, single lab","pmids":["19450626"],"is_preprint":false},{"year":2011,"finding":"Crystal structure of yeast Rrn3 reveals a unique HEAT repeat fold with a surface serine patch. Phosphorylation of this serine patch represses human Pol I transcription; a phospho-mimetic mutation of the patch prevents Rrn3 binding to Pol I in vitro and reduces cell growth and Pol I gene occupancy in vivo. Cross-linking places the Rrn3 binding site on Pol I between subcomplexes AC40/19 and A14/43.","method":"X-ray crystallography, in vitro Pol I binding assay, mutagenesis (phospho-mimetic), ChIP, cell growth assay, protein cross-linking/mass spectrometry","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus mutagenesis, in vitro binding, ChIP, and in vivo growth assay; multiple orthogonal methods in single rigorous study","pmids":["21940764"],"is_preprint":false},{"year":2013,"finding":"Rrn3 is a DNA-binding protein; a domain (residues 382–400) with similarity to the HSF2 DNA-binding domain is required for DNA binding. Mutation or deletion of this domain abolishes DNA binding and transcription in vitro and fails to complement a yeast rrn3-ts mutant, while the mutants retain interaction with rpa43 and SL1, demonstrating that DNA binding is an independent and essential function of Rrn3.","method":"Electrophoretic mobility shift assay (EMSA), deletion and point mutagenesis, in vitro transcription, yeast complementation, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — EMSA, in vitro transcription, mutagenesis, and cross-species complementation with proper controls in single study","pmids":["23393135"],"is_preprint":false},{"year":2013,"finding":"Activated Akt enhances rRNA synthesis by phosphorylating CK2α on a threonine near its N-terminus, which in turn phosphorylates TIF-IA; activated Akt also stabilizes TIF-IA (preventing degradation), induces its translocation to the nucleolus, and enhances its interaction with Pol I.","method":"Co-immunoprecipitation, kinase assays (Akt→CK2α→TIF-IA), RNAi knockdown, pharmacological inhibition (AZD8055, rapamycin), subcellular fractionation/immunofluorescence","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase cascade assays with co-IP and localization, single lab, multiple orthogonal approaches","pmids":["24297901"],"is_preprint":false},{"year":2014,"finding":"A conserved 22 amino-acid peptide within rpa43 is necessary and sufficient for the Rrn3–rpa43 interaction; this peptide inhibits rDNA transcription in vitro and inhibits Pol I transcription and cell division when delivered intracellularly, confirming that the Rrn3–rpa43 interface is functionally essential.","method":"In vitro transcription inhibition assay, peptide transduction (TAT-coupled), cell division assay, in silico conservation analysis","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and cell-based functional assays with defined peptide, single lab","pmids":["25033839"],"is_preprint":false},{"year":2016,"finding":"Cryo-EM structure of the yeast Pol I–Rrn3 complex at 4.8 Å resolution reveals how Rrn3 binding converts an inactive Pol I dimer into an initiation-competent monomer.","method":"Cryo-electron microscopy structural analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure at near-atomic resolution providing direct mechanistic insight into complex assembly","pmids":["27418309"],"is_preprint":false},{"year":2016,"finding":"Heat shock inactivates TIF-IA by inhibiting CK2-dependent phosphorylation at S170/172, repressing rRNA synthesis; this is mechanistically distinct from PAPAS lncRNA-mediated chromatin changes (CHD4/NuRD) but both mechanisms together shut down rDNA transcription under thermo-stress.","method":"Phosphorylation analysis (S170/172), CK2 inhibition, co-immunoprecipitation (CHD4–PAPAS), ChIP, in vitro transcription","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays demonstrating kinase-dependent TIF-IA regulation under heat shock, single lab","pmids":["27257073"],"is_preprint":false},{"year":2016,"finding":"Conditional inactivation of Rrn3 by genetic depletion leads to loss of Pol I occupancy at rDNA but a unique Enhancer Boundary Complex (CTCF/Cohesin) and UBF-bound preinitiation complexes persist independently of Rrn3 or ongoing transcription; preinitiation complex formation is driven by UBF independently of transcription.","method":"Conditional genetic inactivation (mouse cells), high-resolution ChIP-Seq","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-Seq with conditional genetic inactivation, single lab but genome-wide resolution","pmids":["28715449"],"is_preprint":false},{"year":2018,"finding":"TIF-IA degradation (dependent on UBF/p14ARF and S44 phosphorylation status) is a novel upstream event in NF-κB nucleolar stress signaling; specific NF-κB-activating stresses induce TIF-IA degradation, preceded by increased nucleolar size, and blocking TIF-IA degradation blocks stress effects on nucleolar size and NF-κB activation. CDK4 inhibition mimics this pathway.","method":"RNAi knockdown, pharmacological inhibition (CDK4 inhibitor), site-directed mutagenesis (S44), immunoprecipitation, ex vivo tissue culture assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic/pharmacological interventions with mechanistic follow-up, single lab","pmids":["29873780"],"is_preprint":false},{"year":2016,"finding":"LKB1 kinase promotes cell survival under uridine-depleted (AICAR-treated) conditions by maintaining TIF-IA nuclear accumulation and TIF-IA-mediated pre-rRNA synthesis; LKB1 kinase activity (but not kinase-dead mutant) is required for TIF-IA nuclear translocation; a S636D (phospho-mimetic) TIF-IA mutant cannot rescue AICAR-induced apoptosis whereas wild-type or S636A can, placing S636 as a regulatory phosphorylation site.","method":"RNAi knockdown, mutant overexpression (S636A/S636D), subcellular fractionation, cell viability assay, LKB1 reconstitution in LKB1-null cells","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic manipulations and phospho-mutant analysis, single lab","pmids":["26506235"],"is_preprint":false},{"year":2025,"finding":"Under nutrient stress, phosphorylation of RRN3 at S199 is sufficient to divert RRN3 from nucleolus to nuclear plasma, where RRN3 regulates alternative polyadenylation (APA) of autophagy-related mRNAs (e.g., OPTN), enhancing their stability and promoting autophagy in ovarian cancer cells.","method":"Long-read RNA sequencing, PAR-CLIP, subcellular fractionation, site-directed mutagenesis (S199 phosphorylation), in vivo xenograft experiments","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — PAR-CLIP plus phospho-mutagenesis with in vivo validation, single lab, novel non-canonical function","pmids":["41271632"],"is_preprint":false},{"year":2026,"finding":"In senescence, TIF-IA accumulates in the nucleus and nucleolus as an early event; this accumulation is not required for cell cycle arrest but is essential for phenotypic changes to nucleoli, the SASP, and stable senescence. In proliferating cells, TIF-IA binds the cargo receptor p62 (SQSTM1); ATM activation during senescence disrupts this interaction, allowing TIF-IA accumulation. TIF-IA accumulation also elevates ROS levels.","method":"Conditional genetic manipulation, multiple mouse senescence models, co-immunoprecipitation (TIF-IA–p62), ATM inhibitor treatment, immunofluorescence","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic manipulation in multiple in vitro and in vivo models with co-IP demonstrating p62 interaction and ATM-dependent disruption, single lab","pmids":["41466483"],"is_preprint":false},{"year":2024,"finding":"Time-resolved binding assays show that CF (core factor) uses a two-step mechanism (binding + isomerization) to recognize the rDNA promoter; CF-mediated recruitment of the Pol I–Rrn3 complex to the promoter is inefficient, with Pol I rapidly dissociating after recruitment.","method":"Biochemical binding kinetics (time-resolved), biophysical assays, molecular dynamics simulation (yeast system)","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, biophysical assay without functional mutagenesis validation; Rrn3-specific finding is indirect","pmids":["bio_10.1101_2024.10.30.621142"],"is_preprint":true}],"current_model":"RRN3/TIF-IA is a conserved HEAT-repeat factor (crystal structure resolved) that binds directly to RNA Polymerase I (via Pol I subunit A43/RPA43 and between subcomplexes AC40/19 and A14/43) to form an initiation-competent monomeric Pol I complex; it bridges Pol I to the promoter-bound core factor/SL1 (via the Rrn6 subunit and TAF(I) subunits), possesses an intrinsic DNA-binding domain, and functions stoichiometrically—being released from Pol I after initiation (triggered by CK2 phosphorylation at S170/172, reversed by FCP1) and inactivated upon transcription; its activity is controlled by a multi-kinase phosphorylation code (S44 by mTOR-dependent kinases activates; S199 by unknown kinase and T200 by JNK2 inactivate; S633/S649 by ERK/RSK activate; S170/172 by CK2 promote release) that integrates nutrient, growth-factor, and stress signals to couple ribosome synthesis to cell growth, while its depletion triggers nucleolar stress, L11–MDM2-mediated p53 activation, and apoptosis."},"narrative":{"mechanistic_narrative":"RRN3 (TIF-IA in mammals, Rrn3p in yeast) is an essential, growth-regulated RNA polymerase I (Pol I) transcription initiation factor that couples ribosomal RNA synthesis to the physiological state of the cell [PMID:4070001, PMID:8413268, PMID:11265758]. It acts as a stoichiometric bridge: RRN3 binds directly to Pol I—principally through the RPA43/A43 subunit and at an interface located between the AC40/19 and A14/43 subcomplexes—to convert an inactive Pol I dimer into an initiation-competent monomer, and simultaneously contacts the promoter-bound core factor/SL1 (via Rrn6 and the TAF(I)95/TAF(I)68 subunits) to recruit polymerase to the rDNA promoter [PMID:8670901, PMID:11032814, PMID:12393749, PMID:21940764, PMID:27418309]. RRN3 also possesses an intrinsic, separable DNA-binding domain (residues ~382–400) that is required for transcription independently of its protein–protein contacts [PMID:23393135]. Functioning stoichiometrically rather than catalytically, RRN3 is required for forming the first phosphodiester bonds but is then released from Pol I after initiation; its CK2-dependent phosphorylation at S170/172 triggers this release to permit elongation, and FCP1 dephosphorylation regenerates the active factor for new rounds of initiation [PMID:8413268, PMID:12646563, PMID:18559419]. RRN3 activity is governed by a multi-kinase phosphorylation code that integrates nutrient, growth-factor, and stress signals: ERK/RSK phosphorylation at S633/S649 and mTOR-dependent phosphorylation at S44 activate it, whereas S199 and JNK2-mediated T200 phosphorylation inactivate it and drive its translocation away from nucleoli [PMID:12620228, PMID:15004009, PMID:15805466]. Akt-CK2 and LKB1 signaling further regulate its stability and nuclear/nucleolar localization [PMID:24297901, PMID:26506235]. Loss of RRN3 is embryonic lethal in mice and triggers nucleolar stress, L11–MDM2-dependent p53 activation, and apoptosis [PMID:15989966]. Beyond canonical Pol I initiation, RRN3 participates in NF-κB nucleolar stress signaling, senescence (via an ATM-regulated interaction with the cargo receptor p62/SQSTM1), and a non-canonical nuclear role in alternative polyadenylation of autophagy mRNAs [PMID:29873780, PMID:41271632, PMID:41466483].","teleology":[{"year":1985,"claim":"Established the existence of a growth-dependent factor required for accurate Pol I initiation, framing rRNA synthesis as physiologically regulated rather than constitutive.","evidence":"Partial purification of TIF-IA and in vitro transcription reconstitution with purified factors","pmids":["4070001"],"confidence":"High","gaps":["Did not identify the molecular nature of the factor","No mechanism for how activity tracks growth state"]},{"year":1990,"claim":"Showed TIF-IA behaves like a Pol I 'sigma factor', physically associating with the polymerase to license promoter-specific initiation, and linked Pol I phosphorylation to initiation competence.","evidence":"Biochemical co-fractionation, in vitro reconstitution, and phosphatase treatment of Pol I","pmids":["2390974"],"confidence":"High","gaps":["Did not define which subunit mediates the contact","Phospho-target on Pol I/TIF-IA not mapped"]},{"year":1993,"claim":"Defined TIF-IA as a 75 kDa monomer acting at the catalytic step of initiation and released afterward, distinguishing it from stable preinitiation complex components.","evidence":"Purified factor reconstitution, template commitment, and single-round transcription assays","pmids":["8413268"],"confidence":"High","gaps":["Direct binding interface not resolved","No molecular clone yet"]},{"year":1996,"claim":"Identified yeast Rrn3p as the essential factor that stimulates DNA-independent Pol I recruitment to the promoter, establishing the genetically tractable ortholog.","evidence":"Genetic complementation, in vitro transcription with purified Rrn3p, Sarkosyl single-round assays","pmids":["8670901"],"confidence":"High","gaps":["Pol I subunit contact unknown","Conservation to mammals not yet shown"]},{"year":2000,"claim":"Pinned the Pol I–Rrn3 contact to the A43/RPA43 subunit and demonstrated cross-species functional conservation of RRN3 from yeast to human.","evidence":"Yeast conditional genetics, E. coli co-expression, immuno-EM, cross-species complementation, and human cloning/complementation","pmids":["11032814","11265758","10758157"],"confidence":"High","gaps":["Precise A43–Rrn3 interface residues not defined","How Rrn3 simultaneously contacts core factor unclear"]},{"year":2002,"claim":"Mapped distinct TIF-IA surfaces for Pol I (RPA43/PAF67) versus SL1 (TAF(I)95/68) and showed phosphorylation gates the Pol I interaction, mechanistically linking signaling to bridging function.","evidence":"Deletion mapping, co-IP, and comparison of phosphorylated (Sf9) versus bacterial recombinant protein in binding and transcription assays","pmids":["12393749","12015311"],"confidence":"High","gaps":["Identity of the activating kinase(s) not established","Specific phospho-sites not yet mapped"]},{"year":2003,"claim":"Defined the growth-factor arm of regulation (ERK/RSK at S633/S649) and confirmed RRN3 acts stoichiometrically, becoming inactivated upon transcription.","evidence":"Phosphopeptide mapping, kinase assays, S649A mutagenesis, MEK inhibition, and limiting-factor in vitro transcription","pmids":["12620228","12646563"],"confidence":"High","gaps":["Molecular basis of post-initiation inactivation unresolved","How phosphorylation alters the structure not known"]},{"year":2004,"claim":"Placed mTOR upstream of Pol I via opposing phospho-sites (activating S44, inactivating S199) controlling both complex formation and nucleocytoplasmic localization.","evidence":"Rapamycin treatment, phospho-mapping, mutagenesis, co-IP, and immunofluorescence","pmids":["15004009"],"confidence":"High","gaps":["S199 kinase identity unknown","Transport machinery driving relocalization not defined"]},{"year":2005,"claim":"Defined the stress-inactivation arm: JNK2 phosphorylation of T200 disrupts Pol I/SL1 contacts and relocalizes TIF-IA, with genetic KO conferring stress resistance.","evidence":"In vitro kinase assay, phospho-mapping, T200V mutagenesis, co-IP, immunofluorescence, and Jnk2-/- cells","pmids":["15805466"],"confidence":"High","gaps":["How T200 phosphorylation physically blocks both interfaces unclear"]},{"year":2005,"claim":"Established that RRN3 is essential for development and that its loss triggers a defined nucleolar-stress/p53 apoptotic program via L11–MDM2.","evidence":"Mouse knockout, conditional MEF depletion, L11–MDM2 and MDM2–p53 co-IP, and p53 RNAi rescue","pmids":["15989966"],"confidence":"High","gaps":["Whether other ribosomal proteins contribute not addressed","Tissue-specific requirements not dissected"]},{"year":2007,"claim":"Showed Pol I subunits Rpa49/Rpa34 control both Rrn3 recruitment and its release during elongation, and confirmed TOR-dependent recruitment of TIF-IA to rDNA in a metazoan.","evidence":"Yeast genetics/ChIP/epistasis and Drosophila Tif-IA mutant/RNAi/ChIP with TOR epistasis","pmids":["18086878","18086911"],"confidence":"High","gaps":["Mechanism coupling Rpa49 to Rrn3 release not molecularly defined"]},{"year":2008,"claim":"Identified CK2 phosphorylation of S170/172 as the molecular trigger for Rrn3 release from Pol I enabling elongation, with FCP1 reversing it to recycle the factor.","evidence":"Kinase assay, mutagenesis, FRAP, ChIP, co-IP, and covalent tethering to RPA43; plus heparin-resistance recruitment assay distinguishing competent complexes","pmids":["18559419","18590050"],"confidence":"High","gaps":["How phosphorylation weakens the RPA43 interface structurally not shown"]},{"year":2011,"claim":"Provided the first crystal structure (HEAT-repeat fold with a regulatory serine patch) and localized the Pol I binding site, unifying phospho-regulation with structure.","evidence":"X-ray crystallography, phospho-mimetic mutagenesis, in vitro binding, ChIP, and cross-linking/MS","pmids":["21940764"],"confidence":"High","gaps":["Structure of the full Rrn3–Pol I–DNA initiation complex not yet resolved"]},{"year":2013,"claim":"Revealed an intrinsic, essential DNA-binding domain in Rrn3 separable from its protein–protein contacts, adding a direct rDNA-engagement function.","evidence":"EMSA, deletion/point mutagenesis, in vitro transcription, yeast complementation, and co-IP","pmids":["23393135"],"confidence":"High","gaps":["Where on the promoter Rrn3 DNA-binding acts is not mapped"]},{"year":2014,"claim":"Validated the Rrn3–rpa43 interface as a functionally essential, druggable target using a minimal inhibitory peptide.","evidence":"In vitro transcription inhibition, TAT-peptide transduction, and cell division assays","pmids":["25033839"],"confidence":"Medium","gaps":["Therapeutic specificity and in vivo efficacy not established"]},{"year":2016,"claim":"Resolved the architecture of how Rrn3 binding monomerizes inactive Pol I dimers into an initiation-competent state, and extended signaling control (Akt-CK2, LKB1, heat-shock CK2) over RRN3 stability and localization.","evidence":"Cryo-EM of yeast Pol I–Rrn3; kinase cascade co-IP/localization (Akt-CK2; LKB1/S636); CK2-dependent heat-shock inactivation analysis","pmids":["27418309","24297901","26506235","27257073"],"confidence":"Medium","gaps":["Several signaling links rest on single-lab co-IP/localization data","Higher-resolution Rrn3–Pol I structure not available"]},{"year":2017,"claim":"Distinguished UBF/SL1-driven preinitiation complex persistence from Rrn3-dependent Pol I loading, refining the order of assembly at rDNA.","evidence":"Conditional Rrn3 inactivation with high-resolution ChIP-Seq in mouse cells","pmids":["28715449"],"confidence":"Medium","gaps":["How UBF-bound PIC transitions to an Rrn3-loaded competent state mechanistically unclear"]},{"year":2018,"claim":"Placed TIF-IA degradation upstream of NF-κB nucleolar stress signaling, broadening RRN3's role beyond transcription into stress sensing.","evidence":"RNAi, CDK4 inhibition, S44 mutagenesis, and IP in ex vivo culture","pmids":["29873780"],"confidence":"Medium","gaps":["Degradation machinery (E3 ligase) not identified","Direct link from TIF-IA loss to NF-κB activation not fully traced"]},{"year":2025,"claim":"Uncovered a non-canonical nuclear function: S199-phosphorylated RRN3 relocates to the nucleoplasm to regulate alternative polyadenylation of autophagy mRNAs, repurposing a Pol I factor as an RNA-processing regulator under nutrient stress.","evidence":"Long-read RNA-seq, PAR-CLIP, subcellular fractionation, S199 mutagenesis, and xenografts in ovarian cancer cells","pmids":["41271632"],"confidence":"Medium","gaps":["Single-lab finding without independent confirmation","How nuclear RRN3 engages APA machinery is undefined","Generality beyond ovarian cancer unknown"]},{"year":2026,"claim":"Identified an ATM-regulated p62/SQSTM1 interaction controlling TIF-IA accumulation in senescence, where TIF-IA drives nucleolar phenotype, SASP, and ROS independently of cell-cycle arrest.","evidence":"Conditional genetic manipulation in multiple mouse senescence models, TIF-IA–p62 co-IP, and ATM inhibition","pmids":["41466483"],"confidence":"Medium","gaps":["Mechanism linking p62 sequestration to RRN3 stability not detailed","Single-lab finding"]},{"year":null,"claim":"How the full set of regulatory phosphorylations is structurally integrated to switch RRN3 between Pol I-bound, released, relocalized, and non-canonical RNA-binding states remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of phosphorylated RRN3 or the complete initiation complex on DNA","Kinases for several sites (e.g., S199) unidentified","Mechanistic basis of nuclear RNA-processing role undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,6]},{"term_id":"GO:0140223","term_label":"general transcription initiation factor activity","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[21]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,20,24]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[29]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[12,13,19]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[13,19,29]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[12,19]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12,19,30]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,3]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,12,13]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[13,25,27]}],"complexes":["Pol I–Rrn3 initiation complex"],"partners":["RPA43","PAF67","RRN6","TAF1A","TAF1B","FCP1","SQSTM1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NYV6","full_name":"RNA polymerase I-specific transcription initiation factor RRN3","aliases":["Transcription initiation factor IA","TIF-IA"],"length_aa":651,"mass_kda":74.1,"function":"Required for efficient transcription initiation by RNA polymerase I (Pol I). Required for the formation of the competent pre-initiation complex (PIC)","subcellular_location":"Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/Q9NYV6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/RRN3","classification":"Common Essential","n_dependent_lines":380,"n_total_lines":380,"dependency_fraction":1.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RRN3","total_profiled":1310},"omim":[{"mim_id":"621031","title":"POLYMERASE I, RNA, SUBUNIT E; POLR1E","url":"https://www.omim.org/entry/621031"},{"mim_id":"605121","title":"RRN3 HOMOLOG, RNA POLYMERASE I TRANSCRIPTION FACTOR; RRN3","url":"https://www.omim.org/entry/605121"},{"mim_id":"602896","title":"MITOGEN-ACTIVATED PROTEIN KINASE 9; MAPK9","url":"https://www.omim.org/entry/602896"},{"mim_id":"107325","title":"POLYMERASE I, RNA, SUBUNIT G; POLR1G","url":"https://www.omim.org/entry/107325"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli rim","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RRN3"},"hgnc":{"alias_symbol":["DKFZp566E104","TIF-IA"],"prev_symbol":[]},"alphafold":{"accession":"Q9NYV6","domains":[{"cath_id":"-","chopping":"398-564","consensus_level":"medium","plddt":86.3275,"start":398,"end":564},{"cath_id":"1.25.40","chopping":"52-163_175-209","consensus_level":"medium","plddt":89.5634,"start":52,"end":209}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYV6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYV6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYV6-F1-predicted_aligned_error_v6.png","plddt_mean":77.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RRN3","jax_strain_url":"https://www.jax.org/strain/search?query=RRN3"},"sequence":{"accession":"Q9NYV6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NYV6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NYV6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYV6"}},"corpus_meta":[{"pmid":"15004009","id":"PMC_15004009","title":"mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15004009","citation_count":385,"is_preprint":false},{"pmid":"15989966","id":"PMC_15989966","title":"Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15989966","citation_count":219,"is_preprint":false},{"pmid":"12620228","id":"PMC_12620228","title":"ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12620228","citation_count":219,"is_preprint":false},{"pmid":"15805466","id":"PMC_15805466","title":"The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis.","date":"2005","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15805466","citation_count":176,"is_preprint":false},{"pmid":"11032814","id":"PMC_11032814","title":"The recruitment of RNA polymerase I on rDNA is mediated by the interaction of the A43 subunit with Rrn3.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11032814","citation_count":147,"is_preprint":false},{"pmid":"2390974","id":"PMC_2390974","title":"A growth-dependent transcription initiation factor (TIF-IA) interacting with RNA polymerase I regulates mouse ribosomal RNA synthesis.","date":"1990","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2390974","citation_count":114,"is_preprint":false},{"pmid":"11265758","id":"PMC_11265758","title":"TIF-IA, the factor mediating growth-dependent control of ribosomal RNA synthesis, is the mammalian homolog of yeast Rrn3p.","date":"2000","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11265758","citation_count":113,"is_preprint":false},{"pmid":"8670901","id":"PMC_8670901","title":"RRN3 gene of Saccharomyces cerevisiae encodes an essential RNA polymerase I transcription factor which interacts with the polymerase independently of DNA template.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8670901","citation_count":108,"is_preprint":false},{"pmid":"4070001","id":"PMC_4070001","title":"Growth-dependent regulation of rRNA synthesis is mediated by a transcription initiation factor (TIF-IA).","date":"1985","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/4070001","citation_count":94,"is_preprint":false},{"pmid":"9315678","id":"PMC_9315678","title":"The yeast nucleolar protein Cbf5p is involved in rRNA biosynthesis and interacts genetically with the RNA polymerase I transcription factor RRN3.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9315678","citation_count":92,"is_preprint":false},{"pmid":"10758157","id":"PMC_10758157","title":"RNA polymerase I transcription factor Rrn3 is functionally conserved between yeast and human.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10758157","citation_count":91,"is_preprint":false},{"pmid":"21940764","id":"PMC_21940764","title":"Molecular basis of Rrn3-regulated RNA polymerase I initiation and cell growth.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21940764","citation_count":88,"is_preprint":false},{"pmid":"12393749","id":"PMC_12393749","title":"Multiple interactions between RNA polymerase I, TIF-IA and TAF(I) subunits regulate preinitiation complex assembly at the ribosomal gene promoter.","date":"2002","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/12393749","citation_count":82,"is_preprint":false},{"pmid":"18086911","id":"PMC_18086911","title":"Drosophila TIF-IA is required for ribosome synthesis and cell growth and is regulated by the TOR pathway.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18086911","citation_count":81,"is_preprint":false},{"pmid":"12015311","id":"PMC_12015311","title":"Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12015311","citation_count":75,"is_preprint":false},{"pmid":"18086878","id":"PMC_18086878","title":"Two RNA polymerase I subunits control the binding and release of Rrn3 during transcription.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18086878","citation_count":71,"is_preprint":false},{"pmid":"8413268","id":"PMC_8413268","title":"Function of the growth-regulated transcription initiation factor TIF-IA in initiation complex formation at the murine ribosomal gene promoter.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8413268","citation_count":70,"is_preprint":false},{"pmid":"24297901","id":"PMC_24297901","title":"Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24297901","citation_count":66,"is_preprint":false},{"pmid":"18559419","id":"PMC_18559419","title":"Phosphorylation by casein kinase 2 facilitates rRNA gene transcription by promoting dissociation of TIF-IA from elongating RNA polymerase I.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18559419","citation_count":66,"is_preprint":false},{"pmid":"28715449","id":"PMC_28715449","title":"A unique enhancer boundary complex on the mouse ribosomal RNA genes persists after loss of Rrn3 or UBF and the inactivation of RNA polymerase I transcription.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28715449","citation_count":65,"is_preprint":false},{"pmid":"27418309","id":"PMC_27418309","title":"RNA polymerase I-Rrn3 complex at 4.8 Å resolution.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27418309","citation_count":55,"is_preprint":false},{"pmid":"27257073","id":"PMC_27257073","title":"Heat shock represses rRNA synthesis by inactivation of TIF-IA and lncRNA-dependent changes in nucleosome positioning.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27257073","citation_count":55,"is_preprint":false},{"pmid":"23393135","id":"PMC_23393135","title":"DNA binding by the ribosomal DNA transcription factor rrn3 is essential for ribosomal DNA transcription.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23393135","citation_count":34,"is_preprint":false},{"pmid":"12646563","id":"PMC_12646563","title":"Rrn3 becomes inactivated in the process of ribosomal DNA transcription.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12646563","citation_count":30,"is_preprint":false},{"pmid":"29873780","id":"PMC_29873780","title":"Identification of a novel TIF-IA-NF-κB nucleolar stress response pathway.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29873780","citation_count":23,"is_preprint":false},{"pmid":"27641688","id":"PMC_27641688","title":"TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27641688","citation_count":22,"is_preprint":false},{"pmid":"25356674","id":"PMC_25356674","title":"TIF-IA-dependent regulation of ribosome synthesis in drosophila muscle is required to maintain systemic insulin signaling and larval growth.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25356674","citation_count":22,"is_preprint":false},{"pmid":"25033839","id":"PMC_25033839","title":"Selective inhibition of rDNA transcription by a small-molecule peptide that targets the interface between RNA polymerase I and Rrn3.","date":"2014","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/25033839","citation_count":21,"is_preprint":false},{"pmid":"18590050","id":"PMC_18590050","title":"Mammalian Rrn3 is required for the formation of a transcription competent preinitiation complex containing RNA polymerase I.","date":"2008","source":"Gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/18590050","citation_count":20,"is_preprint":false},{"pmid":"18047649","id":"PMC_18047649","title":"Biased exonization of transposed elements in duplicated genes: A lesson from the TIF-IA gene.","date":"2007","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18047649","citation_count":19,"is_preprint":false},{"pmid":"19450626","id":"PMC_19450626","title":"Dynamic subcellular partitioning of the nucleolar transcription factor TIF-IA under ribotoxic stress.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19450626","citation_count":13,"is_preprint":false},{"pmid":"26506235","id":"PMC_26506235","title":"LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26506235","citation_count":9,"is_preprint":false},{"pmid":"35006303","id":"PMC_35006303","title":"Rrn3 gene knockout affects ethanol-induced locomotion in adult heterozygous zebrafish.","date":"2022","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35006303","citation_count":4,"is_preprint":false},{"pmid":"25883228","id":"PMC_25883228","title":"TIF-IA and Ebp1 regulate RNA synthesis in T cells.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25883228","citation_count":2,"is_preprint":false},{"pmid":"41116164","id":"PMC_41116164","title":"NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41116164","citation_count":1,"is_preprint":false},{"pmid":"16358415","id":"PMC_16358415","title":"The association of TIF-IA and polymerase I mediates promoter recruitment and regulation of ribosomal RNA transcription in Acanthamoeba castellanii.","date":"2005","source":"Gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/16358415","citation_count":1,"is_preprint":false},{"pmid":"41271632","id":"PMC_41271632","title":"Nutrient stress diverts RRN3 from rRNA transcription to alternative polyadenylation of autophagy mRNAs in ovarian cancer.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41271632","citation_count":0,"is_preprint":false},{"pmid":"41507426","id":"PMC_41507426","title":"Early growth response 1 promotes RNA polymerase I-directed transcription and cancer growth by activating RRN3 expression.","date":"2026","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41507426","citation_count":0,"is_preprint":false},{"pmid":"42211503","id":"PMC_42211503","title":"Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/42211503","citation_count":0,"is_preprint":false},{"pmid":"41466483","id":"PMC_41466483","title":"Loss of p62 Binding Allows TIF-IA Accumulation in Senescence, Which Promotes Phenotypic Changes to Nucleoli and the Senescence Associated Secretory Phenotype.","date":"2026","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/41466483","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.10.30.621142","title":"Determinants of transcription initiation efficiency and start site selection by RNA polymerase I","date":"2024-10-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.30.621142","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19836,"output_tokens":8277,"usd":0.091831,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17882,"output_tokens":5957,"usd":0.119167,"stage2_stop_reason":"end_turn"},"total_usd":0.210998,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1985,\n      \"finding\": \"TIF-IA is a growth-dependent transcription factor that co-purifies with RNA polymerase I and is required for accurate and efficient Pol I transcription initiation in vitro; its amount or activity fluctuates with the physiological state of cells (absent in quiescent cells).\",\n      \"method\": \"Partial purification of TIF-IA; in vitro transcription reconstitution with purified factors\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro transcription with purified factors, replicated across multiple subsequent studies\",\n      \"pmids\": [\"4070001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"TIF-IA physically associates with RNA polymerase I (converting it into a transcriptionally active holoenzyme capable of initiating at the rDNA promoter) and behaves analogously to a bacterial sigma factor: it is present in limiting amounts, associates with Pol I, is required for initiation, and is separable from the polymerase at certain salt conditions. Dephosphorylation of Pol I abolishes in vitro transcription initiation without affecting non-specific polymerizing activity.\",\n      \"method\": \"Biochemical co-fractionation, in vitro transcription reconstitution, phosphatase treatment of Pol I\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with multiple orthogonal biochemical approaches, foundational finding replicated widely\",\n      \"pmids\": [\"2390974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Purified TIF-IA is a 75 kDa monomeric polypeptide that directly interacts with RNA Pol I and is a bona fide transcription initiation factor; preinitiation complexes can assemble without TIF-IA but formation of the first phosphodiester bonds requires TIF-IA; after initiation, TIF-IA is released from the initiation complex and can facilitate transcription from templates bearing preinitiation complexes lacking TIF-IA. Murine TIF-IA complements both mouse and human growth-inhibited cell extracts.\",\n      \"method\": \"Purified factor reconstitution, template commitment assay, in vitro transcription with purified components\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted with purified factors using multiple orthogonal assays\",\n      \"pmids\": [\"8413268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Yeast Rrn3p is an essential RNA Pol I transcription factor that directly interacts with Pol I independently of DNA template; pre-incubation of Rrn3p with purified Pol I stimulates formation of a Sarkosyl-resistant pre-initiation complex, indicating Rrn3p stimulates Pol I recruitment to the promoter. Rrn3p is not part of the stable pre-initiation complex that supports multiple rounds of transcription.\",\n      \"method\": \"Genetic complementation (rrn3 mutant extracts), immunoaffinity purification, in vitro transcription with purified Rrn3p, template commitment assay, single-round transcription with Sarkosyl\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified components, multiple orthogonal assays (template commitment, single-round transcription, pre-incubation experiments)\",\n      \"pmids\": [\"8670901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Yeast RRN3 is a multicopy suppressor of the cbf5-1 temperature-sensitive mutation; the cbf5-1 mutant shows a defect in rRNA biosynthesis at restrictive temperatures, placing RRN3 in a genetic pathway with CBF5/nucleolar function.\",\n      \"method\": \"High-copy suppressor screen, genetic epistasis in yeast\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic suppressor screen with phenotypic validation in yeast, single lab\",\n      \"pmids\": [\"9315678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Yeast Pol I subunit A43 directly interacts with Rrn3: conditional mutations in A43 disrupt the Pol I–Rrn3 transcriptionally competent complex; the two proteins form a stable complex when co-expressed in E. coli; overexpression of Rrn3 suppresses A43 mutant phenotype; A43 and Rrn3 show synthetic lethality; immunoelectron microscopy confirms their co-localization within the Pol I–Rrn3 complex. Rrn3 also contacts the C-terminus of Rrn6 (core factor subunit) via affinity chromatography.\",\n      \"method\": \"Conditional yeast genetics, co-expression in E. coli, synthetic lethality, immunoelectron microscopy, two-hybrid screen, affinity chromatography\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (genetics, co-expression, EM localization, in vitro affinity), single lab but comprehensive\",\n      \"pmids\": [\"11032814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Human TIF-IA is the mammalian ortholog of yeast Rrn3p: recombinant TIF-IA interacts with Pol I in the absence of template DNA, augments Pol I transcription in vivo, and rescues transcription in extracts from growth-arrested cells in vitro.\",\n      \"method\": \"Molecular cloning, in vitro transcription complementation assay, in vivo transcription augmentation\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro and in vivo functional reconstitution demonstrating conserved activity, single lab with multiple assays\",\n      \"pmids\": [\"11265758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Human Rrn3 functionally rescues a yeast RRN3 disruption strain in vivo; a point mutation in a conserved amino acid compromises function of both yeast and human factors, confirming functional conservation across eukaryotes.\",\n      \"method\": \"Cross-species genetic complementation in yeast, site-directed mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vivo genetic complementation plus mutagenesis confirming conserved residue importance\",\n      \"pmids\": [\"10758157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TIF-IA is associated with a fraction of TIF-IB/SL1 and initiation-competent Pol I. Nutrient starvation, density arrest, and cycloheximide inactivate TIF-IA and impair its association with Pol I. Deletion mapping shows that TIF-IA amino acids 512–609 interact with Pol I subunits RPA43 and PAF67, while residues 411–415 (LARAK motif) are required for association with TAF(I)95 and TAF(I)68 (SL1 subunits).\",\n      \"method\": \"Co-immunoprecipitation, deletion mutant mapping, in vitro interaction assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — domain mapping by deletion analysis and co-IP, single lab with multiple constructs\",\n      \"pmids\": [\"12393749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Phosphorylation state of mammalian Rrn3 regulates its interaction with the rpa43 subunit of RNA Pol I and hence rDNA transcription: cycloheximide inhibits Rrn3 phosphorylation and causes its dissociation from Pol I; Rrn3 produced in Sf9 cells (phosphorylated) but not in bacteria interacts with rpa43 in vitro; neither dephosphorylated nor bacterially-produced Rrn3 restores transcription in cycloheximide-treated cell extracts.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay (Sf9 vs. bacterial recombinant protein), in vitro transcription complementation, phosphatase treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal assays (binding, transcription complementation) with biochemical controls, single lab\",\n      \"pmids\": [\"12015311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ERK and RSK kinases phosphorylate TIF-IA at S633 and S649 in response to growth factor signaling; replacement of S649 with alanine inactivates TIF-IA, inhibits pre-rRNA synthesis, and retards cell growth. PD98059 (MEK inhibitor) blocks TIF-IA activation, confirming MAPK-dependent regulation.\",\n      \"method\": \"Phosphopeptide mapping, site-directed mutagenesis, in vitro kinase assay, PD98059 inhibitor treatment, cell growth assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — phosphopeptide mapping, mutagenesis, in vitro kinase assay, and in vivo functional consequences; replicated in concept by subsequent studies\",\n      \"pmids\": [\"12620228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mammalian Rrn3 functions stoichiometrically (not catalytically) in rDNA transcription: Rrn3 becomes inactivated during transcription reactions, dissociates from Pol I upon transcription, and the inactivated form cannot form a stable complex with Pol I.\",\n      \"method\": \"In vitro transcription assay with limiting factor analysis, sequential transcription reactions, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro transcription reconstitution demonstrating stoichiometric behavior, single lab\",\n      \"pmids\": [\"12646563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"mTOR regulates Pol I transcription through TIF-IA: rapamycin (mTOR inhibitor) inactivates TIF-IA, impairs transcription-initiation complex formation, and causes translocation of TIF-IA from nucleus to cytoplasm. Mechanistically, rapamycin causes hypophosphorylation of S44 and hyperphosphorylation of S199; S44 phosphorylation activates TIF-IA while S199 phosphorylation inactivates it.\",\n      \"method\": \"Rapamycin treatment, phosphopeptide mapping, site-directed mutagenesis, co-immunoprecipitation (TIF-IA with Pol I and SL1), immunofluorescence localization\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — phospho-mapping, mutagenesis, co-IP, and subcellular localization with functional consequences; widely replicated concept\",\n      \"pmids\": [\"15004009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"JNK2 inactivates TIF-IA under stress by phosphorylating it at T200; this phosphorylation impairs TIF-IA interaction with Pol I and TIF-IB/SL1, abrogates initiation complex formation, and causes translocation of TIF-IA from nucleolus to nucleoplasm. T200V substitution or Jnk2 knockout prevents inactivation/translocation and confers stress-resistance of Pol I transcription.\",\n      \"method\": \"In vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis, co-immunoprecipitation, immunofluorescence, genetic knockout (Jnk2-/-)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — kinase assay, mutagenesis, co-IP, localization, and genetic KO with multiple orthogonal readouts\",\n      \"pmids\": [\"15805466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Genetic inactivation of TIF-IA in mice causes embryonic lethality (before/at E9.5). Conditional Cre-mediated depletion in MEFs leads to nucleolar disruption, cell cycle arrest, p53 upregulation, and apoptosis. Elevated p53 results from increased binding of ribosomal protein L11 to MDM2, decreasing MDM2–p53 and MDM2–p19(ARF) interactions. RNAi-mediated loss of p53 rescues proliferation arrest and apoptosis.\",\n      \"method\": \"Homologous recombination knockout in mice, Cre-mediated conditional depletion in MEFs, RNAi, co-immunoprecipitation (L11–MDM2, MDM2–p53), immunofluorescence\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined molecular mechanism (L11–MDM2 co-IP), rescue experiments, multiple orthogonal readouts\",\n      \"pmids\": [\"15989966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In yeast, Pol I subunits Rpa49 and Rpa34 control both the recruitment of Rrn3 to the rDNA promoter and its release during elongation: rpa49 mutants lacking the C-terminus reduce polymerase occupancy and strongly impair Rrn3 release from elongating Pol I; this elongation defect is bypassed by an N-terminal deletion of Rpa43 (rpa43-35,326), placing Rpa43–Rrn3 interaction downstream of Rpa49 function.\",\n      \"method\": \"Yeast genetics (deletion/point mutants), ChIP, 6-azauracil/mycophenolate sensitivity, epistasis analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with ChIP in yeast, single lab\",\n      \"pmids\": [\"18086878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Drosophila TIF-IA is required for rRNA synthesis and cell growth in vivo; the TOR pathway regulates TIF-IA recruitment to rDNA; TIF-IA overexpression maintains rRNA transcription when TOR activity is reduced, placing TIF-IA genetically downstream of TOR in growth control.\",\n      \"method\": \"Drosophila genetic analysis (Tif-IA null mutants), RNAi knockdown, epistasis with TOR pathway, ChIP (TIF-IA occupancy at rDNA)\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic analysis with ChIP and epistasis in a multicellular organism, multiple orthogonal approaches\",\n      \"pmids\": [\"18086911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CK2 phosphorylates TIF-IA at S170/172, triggering release of TIF-IA from Pol I after transcription initiation, which is required for transcription elongation. Inhibition of S170/172 phosphorylation or covalent tethering of TIF-IA to RPA43 inhibits rDNA transcription, perturbs nucleolar structure, and causes cell cycle arrest. Dephosphorylation of S170/172 by FCP1 phosphatase facilitates TIF-IA reassociation with Pol I for new rounds of transcription.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, FRAP, ChIP, co-immunoprecipitation, chemical crosslinking (TIF-IA tethered to RPA43)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — kinase assay, mutagenesis, FRAP, ChIP, co-IP, and biochemical tethering with multiple functional readouts\",\n      \"pmids\": [\"18559419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Mammalian Rrn3 is required for formation of a transcription-competent preinitiation complex: Pol I can be recruited to the rDNA template in the absence of active Rrn3 but the resulting complex cannot initiate transcription; the functional Rrn3-containing complex is ~5-fold more heparin-resistant than the non-functional complex.\",\n      \"method\": \"Novel ChIP-like template recruitment assay, heparin challenge, in vitro transcription\",\n      \"journal\": \"Gene expression\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — biochemical reconstitution with defined functional readout, single lab, single study\",\n      \"pmids\": [\"18590050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TIF-IA dynamically shuttles between cytoplasm, nucleoplasm, and nucleolus with a mean nucleolar residence time of ~30 s; the majority of TIF-IA is in cytoplasm/nucleus with only ~7% in nucleoli at steady state. Import from cytoplasm to nucleus is ~3-fold faster than export, suggesting active importin/exportin-mediated transport. Upon ribotoxic stress, TIF-IA is released from nucleoli with a half-time of ~24 min, downstream of JNK2 activation as the rate-limiting step.\",\n      \"method\": \"Live-cell fluorescence microscopy (GFP-TIF-IA), FRAP, kinetic modeling, JNK2 activity time-course\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative live imaging with kinetic modeling and JNK2 activity validation, single lab\",\n      \"pmids\": [\"19450626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure of yeast Rrn3 reveals a unique HEAT repeat fold with a surface serine patch. Phosphorylation of this serine patch represses human Pol I transcription; a phospho-mimetic mutation of the patch prevents Rrn3 binding to Pol I in vitro and reduces cell growth and Pol I gene occupancy in vivo. Cross-linking places the Rrn3 binding site on Pol I between subcomplexes AC40/19 and A14/43.\",\n      \"method\": \"X-ray crystallography, in vitro Pol I binding assay, mutagenesis (phospho-mimetic), ChIP, cell growth assay, protein cross-linking/mass spectrometry\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus mutagenesis, in vitro binding, ChIP, and in vivo growth assay; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"21940764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rrn3 is a DNA-binding protein; a domain (residues 382–400) with similarity to the HSF2 DNA-binding domain is required for DNA binding. Mutation or deletion of this domain abolishes DNA binding and transcription in vitro and fails to complement a yeast rrn3-ts mutant, while the mutants retain interaction with rpa43 and SL1, demonstrating that DNA binding is an independent and essential function of Rrn3.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), deletion and point mutagenesis, in vitro transcription, yeast complementation, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — EMSA, in vitro transcription, mutagenesis, and cross-species complementation with proper controls in single study\",\n      \"pmids\": [\"23393135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Activated Akt enhances rRNA synthesis by phosphorylating CK2α on a threonine near its N-terminus, which in turn phosphorylates TIF-IA; activated Akt also stabilizes TIF-IA (preventing degradation), induces its translocation to the nucleolus, and enhances its interaction with Pol I.\",\n      \"method\": \"Co-immunoprecipitation, kinase assays (Akt→CK2α→TIF-IA), RNAi knockdown, pharmacological inhibition (AZD8055, rapamycin), subcellular fractionation/immunofluorescence\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase cascade assays with co-IP and localization, single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"24297901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A conserved 22 amino-acid peptide within rpa43 is necessary and sufficient for the Rrn3–rpa43 interaction; this peptide inhibits rDNA transcription in vitro and inhibits Pol I transcription and cell division when delivered intracellularly, confirming that the Rrn3–rpa43 interface is functionally essential.\",\n      \"method\": \"In vitro transcription inhibition assay, peptide transduction (TAT-coupled), cell division assay, in silico conservation analysis\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and cell-based functional assays with defined peptide, single lab\",\n      \"pmids\": [\"25033839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cryo-EM structure of the yeast Pol I–Rrn3 complex at 4.8 Å resolution reveals how Rrn3 binding converts an inactive Pol I dimer into an initiation-competent monomer.\",\n      \"method\": \"Cryo-electron microscopy structural analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure at near-atomic resolution providing direct mechanistic insight into complex assembly\",\n      \"pmids\": [\"27418309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Heat shock inactivates TIF-IA by inhibiting CK2-dependent phosphorylation at S170/172, repressing rRNA synthesis; this is mechanistically distinct from PAPAS lncRNA-mediated chromatin changes (CHD4/NuRD) but both mechanisms together shut down rDNA transcription under thermo-stress.\",\n      \"method\": \"Phosphorylation analysis (S170/172), CK2 inhibition, co-immunoprecipitation (CHD4–PAPAS), ChIP, in vitro transcription\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays demonstrating kinase-dependent TIF-IA regulation under heat shock, single lab\",\n      \"pmids\": [\"27257073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Conditional inactivation of Rrn3 by genetic depletion leads to loss of Pol I occupancy at rDNA but a unique Enhancer Boundary Complex (CTCF/Cohesin) and UBF-bound preinitiation complexes persist independently of Rrn3 or ongoing transcription; preinitiation complex formation is driven by UBF independently of transcription.\",\n      \"method\": \"Conditional genetic inactivation (mouse cells), high-resolution ChIP-Seq\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-Seq with conditional genetic inactivation, single lab but genome-wide resolution\",\n      \"pmids\": [\"28715449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TIF-IA degradation (dependent on UBF/p14ARF and S44 phosphorylation status) is a novel upstream event in NF-κB nucleolar stress signaling; specific NF-κB-activating stresses induce TIF-IA degradation, preceded by increased nucleolar size, and blocking TIF-IA degradation blocks stress effects on nucleolar size and NF-κB activation. CDK4 inhibition mimics this pathway.\",\n      \"method\": \"RNAi knockdown, pharmacological inhibition (CDK4 inhibitor), site-directed mutagenesis (S44), immunoprecipitation, ex vivo tissue culture assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic/pharmacological interventions with mechanistic follow-up, single lab\",\n      \"pmids\": [\"29873780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LKB1 kinase promotes cell survival under uridine-depleted (AICAR-treated) conditions by maintaining TIF-IA nuclear accumulation and TIF-IA-mediated pre-rRNA synthesis; LKB1 kinase activity (but not kinase-dead mutant) is required for TIF-IA nuclear translocation; a S636D (phospho-mimetic) TIF-IA mutant cannot rescue AICAR-induced apoptosis whereas wild-type or S636A can, placing S636 as a regulatory phosphorylation site.\",\n      \"method\": \"RNAi knockdown, mutant overexpression (S636A/S636D), subcellular fractionation, cell viability assay, LKB1 reconstitution in LKB1-null cells\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic manipulations and phospho-mutant analysis, single lab\",\n      \"pmids\": [\"26506235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Under nutrient stress, phosphorylation of RRN3 at S199 is sufficient to divert RRN3 from nucleolus to nuclear plasma, where RRN3 regulates alternative polyadenylation (APA) of autophagy-related mRNAs (e.g., OPTN), enhancing their stability and promoting autophagy in ovarian cancer cells.\",\n      \"method\": \"Long-read RNA sequencing, PAR-CLIP, subcellular fractionation, site-directed mutagenesis (S199 phosphorylation), in vivo xenograft experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PAR-CLIP plus phospho-mutagenesis with in vivo validation, single lab, novel non-canonical function\",\n      \"pmids\": [\"41271632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In senescence, TIF-IA accumulates in the nucleus and nucleolus as an early event; this accumulation is not required for cell cycle arrest but is essential for phenotypic changes to nucleoli, the SASP, and stable senescence. In proliferating cells, TIF-IA binds the cargo receptor p62 (SQSTM1); ATM activation during senescence disrupts this interaction, allowing TIF-IA accumulation. TIF-IA accumulation also elevates ROS levels.\",\n      \"method\": \"Conditional genetic manipulation, multiple mouse senescence models, co-immunoprecipitation (TIF-IA–p62), ATM inhibitor treatment, immunofluorescence\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic manipulation in multiple in vitro and in vivo models with co-IP demonstrating p62 interaction and ATM-dependent disruption, single lab\",\n      \"pmids\": [\"41466483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Time-resolved binding assays show that CF (core factor) uses a two-step mechanism (binding + isomerization) to recognize the rDNA promoter; CF-mediated recruitment of the Pol I–Rrn3 complex to the promoter is inefficient, with Pol I rapidly dissociating after recruitment.\",\n      \"method\": \"Biochemical binding kinetics (time-resolved), biophysical assays, molecular dynamics simulation (yeast system)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, biophysical assay without functional mutagenesis validation; Rrn3-specific finding is indirect\",\n      \"pmids\": [\"bio_10.1101_2024.10.30.621142\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"RRN3/TIF-IA is a conserved HEAT-repeat factor (crystal structure resolved) that binds directly to RNA Polymerase I (via Pol I subunit A43/RPA43 and between subcomplexes AC40/19 and A14/43) to form an initiation-competent monomeric Pol I complex; it bridges Pol I to the promoter-bound core factor/SL1 (via the Rrn6 subunit and TAF(I) subunits), possesses an intrinsic DNA-binding domain, and functions stoichiometrically—being released from Pol I after initiation (triggered by CK2 phosphorylation at S170/172, reversed by FCP1) and inactivated upon transcription; its activity is controlled by a multi-kinase phosphorylation code (S44 by mTOR-dependent kinases activates; S199 by unknown kinase and T200 by JNK2 inactivate; S633/S649 by ERK/RSK activate; S170/172 by CK2 promote release) that integrates nutrient, growth-factor, and stress signals to couple ribosome synthesis to cell growth, while its depletion triggers nucleolar stress, L11–MDM2-mediated p53 activation, and apoptosis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RRN3 (TIF-IA in mammals, Rrn3p in yeast) is an essential, growth-regulated RNA polymerase I (Pol I) transcription initiation factor that couples ribosomal RNA synthesis to the physiological state of the cell [#0, #2, #6]. It acts as a stoichiometric bridge: RRN3 binds directly to Pol I—principally through the RPA43/A43 subunit and at an interface located between the AC40/19 and A14/43 subcomplexes—to convert an inactive Pol I dimer into an initiation-competent monomer, and simultaneously contacts the promoter-bound core factor/SL1 (via Rrn6 and the TAF(I)95/TAF(I)68 subunits) to recruit polymerase to the rDNA promoter [#3, #5, #8, #20, #24]. RRN3 also possesses an intrinsic, separable DNA-binding domain (residues ~382–400) that is required for transcription independently of its protein–protein contacts [#21]. Functioning stoichiometrically rather than catalytically, RRN3 is required for forming the first phosphodiester bonds but is then released from Pol I after initiation; its CK2-dependent phosphorylation at S170/172 triggers this release to permit elongation, and FCP1 dephosphorylation regenerates the active factor for new rounds of initiation [#2, #11, #17]. RRN3 activity is governed by a multi-kinase phosphorylation code that integrates nutrient, growth-factor, and stress signals: ERK/RSK phosphorylation at S633/S649 and mTOR-dependent phosphorylation at S44 activate it, whereas S199 and JNK2-mediated T200 phosphorylation inactivate it and drive its translocation away from nucleoli [#10, #12, #13]. Akt-CK2 and LKB1 signaling further regulate its stability and nuclear/nucleolar localization [#22, #28]. Loss of RRN3 is embryonic lethal in mice and triggers nucleolar stress, L11–MDM2-dependent p53 activation, and apoptosis [#14]. Beyond canonical Pol I initiation, RRN3 participates in NF-κB nucleolar stress signaling, senescence (via an ATM-regulated interaction with the cargo receptor p62/SQSTM1), and a non-canonical nuclear role in alternative polyadenylation of autophagy mRNAs [#27, #29, #30].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Established the existence of a growth-dependent factor required for accurate Pol I initiation, framing rRNA synthesis as physiologically regulated rather than constitutive.\",\n      \"evidence\": \"Partial purification of TIF-IA and in vitro transcription reconstitution with purified factors\",\n      \"pmids\": [\"4070001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the molecular nature of the factor\", \"No mechanism for how activity tracks growth state\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Showed TIF-IA behaves like a Pol I 'sigma factor', physically associating with the polymerase to license promoter-specific initiation, and linked Pol I phosphorylation to initiation competence.\",\n      \"evidence\": \"Biochemical co-fractionation, in vitro reconstitution, and phosphatase treatment of Pol I\",\n      \"pmids\": [\"2390974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which subunit mediates the contact\", \"Phospho-target on Pol I/TIF-IA not mapped\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined TIF-IA as a 75 kDa monomer acting at the catalytic step of initiation and released afterward, distinguishing it from stable preinitiation complex components.\",\n      \"evidence\": \"Purified factor reconstitution, template commitment, and single-round transcription assays\",\n      \"pmids\": [\"8413268\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface not resolved\", \"No molecular clone yet\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified yeast Rrn3p as the essential factor that stimulates DNA-independent Pol I recruitment to the promoter, establishing the genetically tractable ortholog.\",\n      \"evidence\": \"Genetic complementation, in vitro transcription with purified Rrn3p, Sarkosyl single-round assays\",\n      \"pmids\": [\"8670901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pol I subunit contact unknown\", \"Conservation to mammals not yet shown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Pinned the Pol I–Rrn3 contact to the A43/RPA43 subunit and demonstrated cross-species functional conservation of RRN3 from yeast to human.\",\n      \"evidence\": \"Yeast conditional genetics, E. coli co-expression, immuno-EM, cross-species complementation, and human cloning/complementation\",\n      \"pmids\": [\"11032814\", \"11265758\", \"10758157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise A43–Rrn3 interface residues not defined\", \"How Rrn3 simultaneously contacts core factor unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped distinct TIF-IA surfaces for Pol I (RPA43/PAF67) versus SL1 (TAF(I)95/68) and showed phosphorylation gates the Pol I interaction, mechanistically linking signaling to bridging function.\",\n      \"evidence\": \"Deletion mapping, co-IP, and comparison of phosphorylated (Sf9) versus bacterial recombinant protein in binding and transcription assays\",\n      \"pmids\": [\"12393749\", \"12015311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the activating kinase(s) not established\", \"Specific phospho-sites not yet mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the growth-factor arm of regulation (ERK/RSK at S633/S649) and confirmed RRN3 acts stoichiometrically, becoming inactivated upon transcription.\",\n      \"evidence\": \"Phosphopeptide mapping, kinase assays, S649A mutagenesis, MEK inhibition, and limiting-factor in vitro transcription\",\n      \"pmids\": [\"12620228\", \"12646563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of post-initiation inactivation unresolved\", \"How phosphorylation alters the structure not known\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed mTOR upstream of Pol I via opposing phospho-sites (activating S44, inactivating S199) controlling both complex formation and nucleocytoplasmic localization.\",\n      \"evidence\": \"Rapamycin treatment, phospho-mapping, mutagenesis, co-IP, and immunofluorescence\",\n      \"pmids\": [\"15004009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"S199 kinase identity unknown\", \"Transport machinery driving relocalization not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the stress-inactivation arm: JNK2 phosphorylation of T200 disrupts Pol I/SL1 contacts and relocalizes TIF-IA, with genetic KO conferring stress resistance.\",\n      \"evidence\": \"In vitro kinase assay, phospho-mapping, T200V mutagenesis, co-IP, immunofluorescence, and Jnk2-/- cells\",\n      \"pmids\": [\"15805466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How T200 phosphorylation physically blocks both interfaces unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that RRN3 is essential for development and that its loss triggers a defined nucleolar-stress/p53 apoptotic program via L11–MDM2.\",\n      \"evidence\": \"Mouse knockout, conditional MEF depletion, L11–MDM2 and MDM2–p53 co-IP, and p53 RNAi rescue\",\n      \"pmids\": [\"15989966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other ribosomal proteins contribute not addressed\", \"Tissue-specific requirements not dissected\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed Pol I subunits Rpa49/Rpa34 control both Rrn3 recruitment and its release during elongation, and confirmed TOR-dependent recruitment of TIF-IA to rDNA in a metazoan.\",\n      \"evidence\": \"Yeast genetics/ChIP/epistasis and Drosophila Tif-IA mutant/RNAi/ChIP with TOR epistasis\",\n      \"pmids\": [\"18086878\", \"18086911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling Rpa49 to Rrn3 release not molecularly defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified CK2 phosphorylation of S170/172 as the molecular trigger for Rrn3 release from Pol I enabling elongation, with FCP1 reversing it to recycle the factor.\",\n      \"evidence\": \"Kinase assay, mutagenesis, FRAP, ChIP, co-IP, and covalent tethering to RPA43; plus heparin-resistance recruitment assay distinguishing competent complexes\",\n      \"pmids\": [\"18559419\", \"18590050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phosphorylation weakens the RPA43 interface structurally not shown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Provided the first crystal structure (HEAT-repeat fold with a regulatory serine patch) and localized the Pol I binding site, unifying phospho-regulation with structure.\",\n      \"evidence\": \"X-ray crystallography, phospho-mimetic mutagenesis, in vitro binding, ChIP, and cross-linking/MS\",\n      \"pmids\": [\"21940764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full Rrn3–Pol I–DNA initiation complex not yet resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed an intrinsic, essential DNA-binding domain in Rrn3 separable from its protein–protein contacts, adding a direct rDNA-engagement function.\",\n      \"evidence\": \"EMSA, deletion/point mutagenesis, in vitro transcription, yeast complementation, and co-IP\",\n      \"pmids\": [\"23393135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Where on the promoter Rrn3 DNA-binding acts is not mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Validated the Rrn3–rpa43 interface as a functionally essential, druggable target using a minimal inhibitory peptide.\",\n      \"evidence\": \"In vitro transcription inhibition, TAT-peptide transduction, and cell division assays\",\n      \"pmids\": [\"25033839\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Therapeutic specificity and in vivo efficacy not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolved the architecture of how Rrn3 binding monomerizes inactive Pol I dimers into an initiation-competent state, and extended signaling control (Akt-CK2, LKB1, heat-shock CK2) over RRN3 stability and localization.\",\n      \"evidence\": \"Cryo-EM of yeast Pol I–Rrn3; kinase cascade co-IP/localization (Akt-CK2; LKB1/S636); CK2-dependent heat-shock inactivation analysis\",\n      \"pmids\": [\"27418309\", \"24297901\", \"26506235\", \"27257073\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Several signaling links rest on single-lab co-IP/localization data\", \"Higher-resolution Rrn3–Pol I structure not available\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Distinguished UBF/SL1-driven preinitiation complex persistence from Rrn3-dependent Pol I loading, refining the order of assembly at rDNA.\",\n      \"evidence\": \"Conditional Rrn3 inactivation with high-resolution ChIP-Seq in mouse cells\",\n      \"pmids\": [\"28715449\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How UBF-bound PIC transitions to an Rrn3-loaded competent state mechanistically unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed TIF-IA degradation upstream of NF-κB nucleolar stress signaling, broadening RRN3's role beyond transcription into stress sensing.\",\n      \"evidence\": \"RNAi, CDK4 inhibition, S44 mutagenesis, and IP in ex vivo culture\",\n      \"pmids\": [\"29873780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Degradation machinery (E3 ligase) not identified\", \"Direct link from TIF-IA loss to NF-κB activation not fully traced\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Uncovered a non-canonical nuclear function: S199-phosphorylated RRN3 relocates to the nucleoplasm to regulate alternative polyadenylation of autophagy mRNAs, repurposing a Pol I factor as an RNA-processing regulator under nutrient stress.\",\n      \"evidence\": \"Long-read RNA-seq, PAR-CLIP, subcellular fractionation, S199 mutagenesis, and xenografts in ovarian cancer cells\",\n      \"pmids\": [\"41271632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding without independent confirmation\", \"How nuclear RRN3 engages APA machinery is undefined\", \"Generality beyond ovarian cancer unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified an ATM-regulated p62/SQSTM1 interaction controlling TIF-IA accumulation in senescence, where TIF-IA drives nucleolar phenotype, SASP, and ROS independently of cell-cycle arrest.\",\n      \"evidence\": \"Conditional genetic manipulation in multiple mouse senescence models, TIF-IA–p62 co-IP, and ATM inhibition\",\n      \"pmids\": [\"41466483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking p62 sequestration to RRN3 stability not detailed\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the full set of regulatory phosphorylations is structurally integrated to switch RRN3 between Pol I-bound, released, relocalized, and non-canonical RNA-binding states remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of phosphorylated RRN3 or the complete initiation complex on DNA\", \"Kinases for several sites (e.g., S199) unidentified\", \"Mechanistic basis of nuclear RNA-processing role undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 6]},\n      {\"term_id\": \"GO:0140223\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 20, 24]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [12, 13, 19]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [13, 19, 29]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [12, 19]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12, 19, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 12, 13]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [13, 25, 27]}\n    ],\n    \"complexes\": [\n      \"Pol I–Rrn3 initiation complex\"\n    ],\n    \"partners\": [\n      \"RPA43\",\n      \"PAF67\",\n      \"RRN6\",\n      \"TAF1A\",\n      \"TAF1B\",\n      \"FCP1\",\n      \"SQSTM1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":8,"faith_pct":87.5}}